Acorda Therapeutics Company
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.
Investors
%20.jpg)
Funding Status:
IPO
Headquarters:
United States
Founded Date:
1995
Investor Type:
Company
Investment Stage:
N/A
Technology:
Immunotherapy
Employee Number:
251-500
Number Of Exists:
N/A
Estimated Revenue:
$50M to $100M
Industry:
Loss of Proteostasis